Yes, it definitely doesn't work.
That's why they have continued to spend millions on the HBV project and are going down the exact same pathway as the HCV. Two failed trials will be much better than just one. We need to prove it doesn't work, twice.
All patients are monitored the same.
BLT.AX says CEO and Managing Director Dr Peter French Resigned, page-48
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)